Mr. Glavine is a serial entrepreneur in emerging medicine

Mr. Glavine was a co-founder of Truverra Inc., a Health Canada licensed producer of medical cannabis that was acquired by Supreme Cannabis, now a subsidiary of Canopy Growth Corporation (NASDAQ:CGC)

Mr. Herath has over 30 years of experience in research and product development for global pharmaceutical and chemical manufacturing companies, including Novo Nordisk (NYSE:NVO)

Mr. Herath is a licensed chemist in Ontario and has significant experience in analytical chemistry and molecular modification to create fit for purpose molecules

Dr. Ledonio is a chronic pain and drug development professional with over 10 years of experience in setting up clinical trials, navigating regulatory requirements, and corresponding with the FDA

Dr. Ledonio has successfully developed clinical development programs to generate evidence for regulatory and commercial needs within the product development lifecycle

Mr. Lu has significant experience developing novel analogues and supplying the chemical research industry in Canada

Mr. Lu is an organic chemist and is passionate about creating medicines that can help billions of people and has developed a proprietary process to synthesize novel analogues

Mr. Brown is an entrepreneur with over a decade of experience in investment banking and venture capital

Mr. Brown is a CFA charter holder and holds a BBA in Finance from the University of New Brunswick

Dr. Lee has over 15 years of experience working in drug development for large pharmaceutical companies

Dr. Lee is the Director of R&D Program Management for BioNTech SE and was previously the Head of Innovation, External R&D at Dr. Reddy’s Laboratories (NYSE: RDY)

Ms. Erato is a pharmaceutical executive with over 15 years experience in clinical research operations

Ms. Erato is also the CEO of Spaulding Clinical, a leading CRO in the U.S. in early stage clinical development

Clinical Professor in Anesthesiology, University of California, San Diego

Dr. Castellanos has conducted significant research in Neurorehabilitation, Pain Management as well as Potential Use of Psychedelics for Chronic Pain

Dr. Manson is a Professor at Queen's University School of Kinesiology and Health Studies

Dr. Manson’s research themes include the role of brain and spinal neural networks in the rapid control of movements to somatosensory targets, and multi-sensory perception during movements to somatosensory and visual targets

Dr. Mason holds a PhD in Neuroscience and Kinesiology from the University of Toronto

Dr. Bigos is a Professor of Medicine and Pharmacology at the Johns Hopkins University School of Medicine

Dr. Bigos was previously an Investigator at the Lieber Institute for Brain Development focused on neuropsychiatric drug development

Dr. Bigos has completed a Postdoctoral Fellowship in the Clinical Brain Disorders Branch of the Intramural Research Program of the National Institute of Mental Health

Dr. Carr is a Lead investigator at the Lieber Institute for Brain Development

Dr. Carr is a Professor of Pharmacology at Johns Hopkins University School of Medicine

Dr. Carr has completed a postdoctoral fellowship in the Clinical Brain Disorders Branch of the NIMH

Dr. Foster is a Professor in the Department of Psychiatry and Behavioural Neurosciences at McMaster University

Dr. Foster’s research focuses on the role of immune-brain and gut-brain interactions on neurodevelopment and behaviour

Dr. Foster is a Scientific Associate with the University Health Network in Toronto and a Scientist at St. Michael’s Hospital

Dr. Thomas Ungar is a Professor at the University of Toronto's Department of Psychiatry

Dr. Ungar is currently an Active Staff Psychiatrist at North York General Hospital and has previously held the position of Chief of Psychiatry

He has also practiced at St. Michael's Hospital in Toronto, both as an Active Staff Psychiatrist and Psychiatrist-in-Chief